A synthetic vaccine consisting of a tumor-associated sialyl-T(N)-MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response.
Kaiser
Anton
A
Johannes Gutenberg-Universität Main, Institut für Organische Chemie, Duesbergweg 10-14, 55128 Mainz, Germany.
Gaidzik
Nikola
N
Westerlind
Ulrika
U
Kowalczyk
Danuta
D
Hobel
Alexandra
A
Schmitt
Edgar
E
Kunz
Horst
H
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D019496:Cancer Vaccines / Q000138:chemical synthesis / Q000276:immunology; D006020:Glycopeptides / Q000276:immunology*; D006801:Humans; D007107:Immune System / Q000276:immunology; D051379:Mice; D008822:Mice, Transgenic; D015394:Molecular Structure; D018396:Mucin-1 / Q000276:immunology*; D010446:Peptide Fragments / Q000276:immunology*; D013745:Tetanus Toxoid / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D006020:Glycopeptides; C116055:MUC1 tandem repeat peptide; D018396:Mucin-1; D010446:Peptide Fragments; D013745:Tetanus Toxoid; D014614:Vaccines, Synthetic